An available strategy for nasal brain transport of nanocomposite based on PAMAM dendrimers via in situ gel

50Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

Polyamidoamine (PAMAM) dendrimers are efficient drug carriers. The presence of a physiological pathway for nasal brain transport provides a potential path for direct brain-targeted delivery of dendrimer nanocomposites. In this study, we synthesized PAMAM dendrimer composites with a nanoscale size; the particle size of PAE (Paeonol)/mPEG (the heterofunctional PEG polymer with a methoxy)-PAMAM G5.NHAc and mPEG-PAMAM G5.NH 2 -FITC were 72.41 ± 11.58 nm and 96.51 ± 7.77 nm, and the zeta potential of PAE/mPEG-PAMAM G5.NHAc and mPEG-PAMAM G5.NH 2 -FITC were + 0.57 ± 0.11 mv and + 9.60 ± 0.41 mv, respectively. The EE% and DL% of PAE in PAE/mPEG-PAMAM G5.NHAc were 53.77% and 13.92%, respectively. PAE/mPEG-PAMAM G5.NHAc/DGG ionic-sensitive in situ gel was prepared, the viscosity of solution and gel state were 112 ± 3.2 mPa and 1403 ± 38.5 mPa, respectively. The in vitro goat mucoadhesive strength of the gel was 4763.36 ± 85.39 dyne/cm 2 . In situ gel system was proven to be a non-Newtonian pseudo-plastic fluid with shear thinning, thixotropy and yield stress. The optimal model of PAE released from PAE/mPEG-PAMAM G5.NHAc and PAE/mPEG-PAMAM G5.NHAc/DGG were the Higuchi equation and the Korsmeyer-Peppas equation, respectively. The cytotoxicity of the nanocomposites showed a concentration-dependence, and the cell viabilities of PAE/mPEG-PAMAM G5.NHAc were both higher than 95% between 0.0001 µM and 10 µM. mPEG-PAMAM G5.NH 2 -FITC was efficiently taken up by cells and exhibited strong fluorescence in the cytoplasm and nucleus. Significant accumulation of nanocomposites was observed in the brain after administration of the in situ gel group, and maximum accumulation was reached at 12 h. A small amount of accumulation was observed in the nanocomposite solution group only at 2 h. Therefore, the direct nasal brain transport efficiency of PAMAM dendrimer nanocomposites can be significantly improved after combining with in situ gel. PAMAM dendrimer nanocomposite/DGG is a potential drug delivery system for nasal brain transport.

References Powered by Scopus

Methods to Assess Shear-Thinning Hydrogels for Application As Injectable Biomaterials

332Citations
N/AReaders
Get full text

A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas

288Citations
N/AReaders
Get full text

Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles

238Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Progress in nasal drug delivery systems

110Citations
N/AReaders
Get full text

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

93Citations
N/AReaders
Get full text

Chemistry, pharmacokinetics, pharmacology and recent novel drug delivery systems of paeonol

82Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Xie, H., Li, L., Sun, Y., Wang, Y., Gao, S., Tian, Y., … Zhang, L. (2019). An available strategy for nasal brain transport of nanocomposite based on PAMAM dendrimers via in situ gel. Nanomaterials, 9(2). https://doi.org/10.3390/nano9020147

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

62%

Researcher 6

21%

Lecturer / Post doc 3

10%

Professor / Associate Prof. 2

7%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 16

59%

Medicine and Dentistry 5

19%

Chemistry 4

15%

Computer Science 2

7%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free